Friday, May 27, 2016 9:17:07 AM
NNVC does have employees. The work may be segregated in the cGMP facility and there may be a joint agreement for Trade Secret ownership between Theracour and NNVC, but the Trade Secrets for developing, the verification/validation (call it QC for quality control) processes for drug production scale up do exist, by virtue of the fact that the QC process for 200g production is locked down, while the QC process for 500g and larger batch sizes are in development and are of significant, proprietary value to both companies. Certainly the Trade Secrets that have been developed at the cGMP, strengthens the licensing agreements and does not circumvent those agreements. But if the company were ever to sell out to a big pharma for larger scale production, the QC Trade Secrets are the key, since they are the only proven methods to scaling up production beyond Diwan's numerous patents.
I have direct experience with Trade Secrets and I have patents myself as an employee (System Engineer) for a large company. I have gone through much training on the subjects and am versed in the laws protecting such IP. My argument is valid whether you acknowledge it or not. Some simple research on Trade Secrets makes my point:
Who Owns a Trade Secret?
A trade secret is a type of of intellectual property, and it comes in many different forms. There are no actual laws governing trade secret ownership, but trade secrets generally pertain to information held by a company rather than by an individual. So typically employers or hiring parties own trade secret information even if it is generated by an employee.
http://www.legalmatch.com/law-library/article/ownership-of-a-trade-secret.html
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM